awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35278165-E3BBAEDF-008B-4DFC-AC48-8D272F647F37
Q35278165-E3BBAEDF-008B-4DFC-AC48-8D272F647F37
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35278165-E3BBAEDF-008B-4DFC-AC48-8D272F647F37
Anti-platelet therapy: ADP receptor antagonists.
P2860
Q35278165-E3BBAEDF-008B-4DFC-AC48-8D272F647F37
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35278165-E3BBAEDF-008B-4DFC-AC48-8D272F647F37
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2542be7b0d15585f2009613b5228f839a40aa4dc
P2860
The P2Y12 antagonists, 2-methylthioadenosine 5'-monophosphate triethylammonium salt and cangrelor (ARC69931MX), can inhibit human platelet aggregation through a Gi-independent increase in cAMP levels.